2011Medical Journal of Chinese People's HealthRequires access

A comparative study of Duloxetine versus Escitalopram in the treatment of depression

Zhou Xiang

Open publisher page 0 citations

Abstract

Objective:To observe the efficacy and safety of Duloxetine and Escitalopram in the treatment of depression.Methods:Sixty-six patients with depression were randomly divided into Duloxetine group(n=33) and Escitalopram group(n=33).The patients were treated with Duloxetine(40~60mg/d)or Escitalopram(10~15mg/d) for 6 weeks.The efficacy was assessed with Hamilton depression rating scale(HAMD17) and the side effects were assessed with treatment emergent symptoms scale(TESS).Results: After the first week of treatment,the response rate was 36.36% in Duloxetine group and 33.33% in Escitalopram group without significant difference(P0.05).After the 6-weeks treatment,the response rates in Duloxetine group and Escitalopram group were 93.93% and 90.90% respectively,without significant difference(P0.05).There were no significant difference in side effect between these two groups.Conclusions: Duloxetine and Escitalopram are both effective and safe in the treatment of depression.

About this research paper

What this paper is about

Objective:To observe the efficacy and safety of Duloxetine and Escitalopram in the treatment of depression.Methods:Sixty-six patients with depression were randomly divided into Duloxetine group(n=33) and Escitalopram group(n=33).The patients were treated with Duloxetine(40~60mg/d)or Escitalopram(10~15mg/d) for 6 weeks.The efficacy was assessed with Hamilton depression rating scale(HAMD17) and the side effects were assessed with treatment emergent symptoms scale(TESS).Results: After the first week of treatment,the response rate was 36.36% in Duloxetine group and 33.33% in Escitalopram group without significant difference(P0.05).After the 6-weeks treatment,the response rates in Duloxetine group and Escitalopram group were 93.93% and 90.90% respectively,without significant difference(P0.05).There were no significant difference in side effect between these two groups.Conclusions: Duloxetine and Escitalopram are both effective and safe in the treatment of depression.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To observe the efficacy and safety of Duloxetine and Escitalopram in the treatment of depression.Methods:Sixty-six patients with depression were randomly divided into Duloxetine group(n=33) and Escitalopram group(n=33).The patients were treated with Duloxetine(40~60mg/d)or Escitalopram(10~15mg/d) for 6 weeks.The efficacy was assessed with Hamilton depression rating scale(HAMD17) and the side effects were assessed with treatment emergent symptoms scale(TESS).Results: After the first week of treatment,the response rate was 36.36% in Duloxetine group and 33.33% in Escitalopram group without significant difference(P0.05).After the 6-weeks treatment,the response rates in Duloxetine group and Escitalopram group were 93.93% and 90.90% respectively,without significant difference(P0.05).There were no significant difference in side effect between these two groups.Conclusions: Duloxetine and Escitalopram are both effective and safe in the treatment of depression.

Key concepts: Escitalopram, Duloxetine, Depression (economics), Duloxetine Hydrochloride, Significant difference, Internal medicine, Psychology, Medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
A comparative study of Duloxetine versus Escitalopram in the treatment of depression — Research Paper | ScholarLens